MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia
DOI 10.1371/journal.pmed.0030270
Y Pikman BH Lee T Mercher, et al. 2006 MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia PLOS Med 3 e270 10.1371/journal.pmed.0030270 16834459 (Pubitemid 44125998)
MPL515 mutations in myeloproliferative and other myeloid disorders: A study of 1182 patients
DOI 10.1182/blood-2006-04-018879
AD Pardanani RL Levine T Lasho, et al. 2006 MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients Blood 108 3472 3476 10.1182/blood-2006-04-018879 1:CAS:528:DC%2BD28Xht1ahsLzI 16868251 (Pubitemid 44776889)
R Chaligne C Tonetti R Besancenot L Roy C Marty P Mossuz JJ Kiladjian, et al. 2008 New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition Leukemia 22 8 1557 1566 10.1038/leu.2008.137 1:CAS:528:DC%2BD1cXpslSnsLY%3D 18528423
An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor
DOI 10.1182/blood-2005-06-2600
J Staerk C Lacout T Sato SO Smith W Vainchenker SN Constantinescu 2006 An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor Blood 107 1864 1871 10.1182/blood-2005-06-2600 1:CAS:528:DC%2BD28XitFChsbg%3D 16249382 (Pubitemid 43289364)
Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin
DOI 10.1182/blood-2003-10-3471
J Ding H Komatsu A Wakita M Kato-Uranishi M Ito A Satoh, et al. 2004 Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin Blood 103 4198 4200 10.1182/blood-2003-10-3471 1:CAS:528:DC%2BD2cXkvVyit7g%3D 14764528 (Pubitemid 38685363)